Identification of new biomarkers in cardiac ischemia
Recruiting
- Conditions
- I25I25.1Chronic ischaemic heart diseaseAtherosclerotic heart disease
- Registration Number
- DRKS00030534
- Lead Sponsor
- Klinik für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients who have a clinical indication for an imaging-based cardiac stress test; Patients who consent to participate in the study
Exclusion Criteria
if the inclusion criteria are not met
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prediction of positive or negative cardiac stress test result
- Secondary Outcome Measures
Name Time Method Prediction of coronary artery disease
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What new biomarkers are being investigated for cardiac ischemia in DRKS00030534?
How do emerging biomarkers in DRKS00030534 compare to traditional markers like troponin for ischemic heart disease?
What molecular pathways are targeted by potential biomarkers in DRKS00030534 for atherosclerotic heart disease?
What adverse events are associated with biomarker-based diagnostics in chronic ischaemic heart disease trials?
How might biomarkers identified in DRKS00030534 influence patient selection for ischemia treatments like revascularization or antiplatelet therapy?